31 related articles for article (PubMed ID: 3484646)
1. Ferritin stimulation of a monokine inhibitor of lipopolysaccharide-augmented myelopoiesis is ferroxidase dependent.
Kreisberg R; Broxmeyer HE; Moore RN
Infect Immun; 1994 Jul; 62(7):2991-4. PubMed ID: 8005686
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte-derived inhibitory activity in patients with myelodysplastic syndrome.
Cukrová V; Neuwirtová R; Cermák J; Malasková V; Neuwirt J
Blut; 1987 Sep; 55(3):165-71. PubMed ID: 3620712
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of inhibitory activity derived from cells of MDS patients and ML-2 cell line by monoclonal antibodies against H and L-subunit-rich ferritins.
Cukrová V; Neuwirtová R
Blut; 1990 Nov; 61(5):278-81. PubMed ID: 2271775
[TBL] [Abstract][Full Text] [Related]
4. Mutated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo: a link between ferritin ferroxidase activity and biological function.
Broxmeyer HE; Cooper S; Levi S; Arosio P
Proc Natl Acad Sci U S A; 1991 Feb; 88(3):770-4. PubMed ID: 1992468
[TBL] [Abstract][Full Text] [Related]
5. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
6. Identification of leukemia cell-derived inhibitory activity (LIA) in conditioned media from human myeloid leukemic cell line ML-2.
Cukrová V; Hrkal Z; Koprivová H; Neuwirt J
Blut; 1986 Jan; 52(1):51-8. PubMed ID: 3484646
[TBL] [Abstract][Full Text] [Related]
7. Acidic isoferritins (leukemia-associated inhibitory activity) fail to inhibit blast proliferation in acute myelogenous leukemia.
Taetle R
Blood; 1981 Sep; 58(3):653-7. PubMed ID: 6973349
[TBL] [Abstract][Full Text] [Related]
8. Production, characteristics and mode of action of hemopoietic growth inhibitors in myeloid leukemias.
Olsson I; Olofsson T
Med Oncol Tumor Pharmacother; 1985; 2(1):1-6. PubMed ID: 3877222
[TBL] [Abstract][Full Text] [Related]
9. [Determination of inhibitory activity derived from leukemic cells and its use in clinical practice].
Cukrová V; Neuwirtová R; Novák F; Cermák J
Vnitr Lek; 1987 Mar; 33(3):241-7. PubMed ID: 3499031
[No Abstract] [Full Text] [Related]
10. SMALL-SCALE ISOLATION OF FERRITIN FOR THE ASSAY OF THE INCORPORATION OF 14C-LABELLED AMINO ACIDS.
DRYSDALE JW; MUNRO HN
Biochem J; 1965 Jun; 95(3):851-8. PubMed ID: 14342525
[TBL] [Abstract][Full Text] [Related]
11. Monocyte-macrophage-derived acidic isoferritins: normal feedback regulators of granulocyte-macrophage progenitor cells in vitro.
Broxmeyer HE; Bognacki J; Ralph P; Dörner MH; Lu L; Castro-Malaspina H
Blood; 1982 Sep; 60(3):595-607. PubMed ID: 6980676
[TBL] [Abstract][Full Text] [Related]
12. Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages.
Broxmeyer HE; Bognacki J; Dorner MH; de Sousa M
J Exp Med; 1981 Jun; 153(6):1426-44. PubMed ID: 6972999
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
